NEXGEL, Inc.
$3.53
0.16 (4.75%)
NXGL Price Chart
| Basic | |
|---|---|
| Market Cap | $31.71M |
| Price | $3.53 |
| 52 Week Range | 1.84-5.1 |
| Beta | 0.73 |
| Margins | |
| Gross Profit Margin | 31.28% |
| Operating Profit Margin | -40.91% |
| Net Profit Margin | -37.77% |
| Valuation (TTM) | |
| P/E Ratio | -5.10 |
| Price to Sales Ratio | 3.03 |
| Price to Book Ratio | 2.91 |
| PEG Ratio | -0.49 |
Industry
Medical - Instruments & Supplies
Sector
Healthcare
Full-Time Employees
19
Website
IPO Date
2021-12-22T00:00:00.000Z
Description
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Phone
215 702 8550
Address
2150 Cabot Boulevard West, Langhorne, PA, 19047, US
CIK
0001468929